Financhill
Buy
69

CAH Quote, Financials, Valuation and Earnings

Last price:
$164.94
Seasonality move :
2.22%
Day range:
$162.24 - $165.11
52-week range:
$93.17 - $165.11
Dividend yield:
1.23%
P/E ratio:
25.73x
P/S ratio:
0.18x
P/B ratio:
--
Volume:
2.2M
Avg. volume:
2.1M
1-year change:
63.36%
Market cap:
$39.4B
Revenue:
$226.8B
EPS (TTM):
$6.41

Earnings Data

Next earnings date for CAH
Aug 14
2025
Most recent earnings per share
$2.10
Missed by $0.05
(May 1/2025)
Consensus Estimate
$2.15
(May 1/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CAH Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/14/2025 Q2 $60.9B -- -- $2.03 --
05/01/2025 Q1 $55.3B $54.9B $2.10 $2.15 -$0.05
01/30/2025 Q4 $55B $55.3B $1.65 $1.76 -$0.11
11/01/2024 Q3 $50.8B $52.3B $1.70 $1.62 $0.08
08/14/2024 Q2 $58.6B $59.9B $0.96 $1.73 -$0.77
05/02/2024 Q1 $56.1B $54.9B $1.07 $1.95 -$0.88
02/01/2024 Q4 $56.9B $57.4B $1.50 $1.60 -$0.10
11/03/2023 Q3 $54.9B $54.7B -$0.05 $1.41 -$1.46
08/15/2023 Q2 $52.7B $53.4B -$0.25 $1.48 -$1.73
05/04/2023 Q1 $49.6B $50.5B $1.34 $1.49 -$0.15
02/02/2023 Q4 -- $51.5B -$0.50 -- --
11/04/2022 Q3 -- $49.6B $0.40 -- --
08/11/2022 Q2 -- $47.1B $0.50 -- --
05/05/2022 Q1 -- $44.8B -$5.05 -- --
02/03/2022 Q4 -- $45.5B $0.17 -- --
11/09/2021 Q3 -- $44B $0.94 -- --
08/05/2021 Q2 -- $42.6B $0.40 -- --
05/06/2021 Q1 -- $39.3B $0.40 -- --
02/05/2021 Q4 -- $41.5B $2.13 -- --
11/04/2020 Q3 -- $39.1B -$0.86 -- --
08/05/2020 Q2 -- $36.7B $2.23 -- --
05/11/2020 Q1 -- $39.2B $1.19 -- --
02/06/2020 Q4 -- $39.7B $0.75 -- --
11/07/2019 Q3 -- $37.3B -$16.65 -- --
08/08/2019 Q2 -- $37.4B $0.65 -- --
05/09/2019 Q1 -- $35.2B $0.99 -- --
02/07/2019 Q4 -- $37.7B $0.93 -- --
11/08/2018 Q3 -- $35.2B $1.94 -- --
08/06/2018 Q2 -- $35.3B -$3.76 -- --
05/03/2018 Q1 -- $33.6B $0.81 -- --
02/08/2018 Q4 -- $35.2B $3.33 -- --
11/06/2017 Q3 -- $32.6B $0.36 -- --
08/02/2017 Q2 -- $33B $0.86 -- --
05/01/2017 Q1 -- $31.8B $1.20 -- --
02/07/2017 Q4 -- $33.2B $1.02 -- --
10/31/2016 Q3 -- $32B $0.96 -- --
08/02/2016 Q2 -- $31.4B $1.02 -- --
04/28/2016 Q1 -- $30.7B $1.17 -- --
02/01/2016 Q4 -- $31.4B $0.98 -- --
11/02/2015 Q3 -- $28.1B $1.15 -- --
07/30/2015 Q2 -- $27.5B $0.88 -- --

Cardinal Health Earnings Questions

  • How Much did Cardinal Health Generate in Revenue Last Quarter?

    Cardinal Health reported $54.9B worth of top line sales in its most recent quarter.

  • Did Cardinal Health Beat Earnings Last Quarter?

    Cardinal Health announced earnings per share of $2.10 which represents a miss of analyst forecast a $2.15 per share.

  • Is Cardinal Health Profitable?

    Cardinal Health reported $2.1B that represents $8.81 per share over the last quarter.

  • What is the Analyst Consensus for Cardinal Health EPS Next Year?

    Cardinal Health's earnings are forecast to grow from $3.45 per share to $7.36 per share next year representing an increase of 135.56%.

  • When is Cardinal Health's Earnings Date?

    Cardinal Health's next earnings date is August 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Reddit Stock Be In 5 Years?
Where Will Reddit Stock Be In 5 Years?

On a wet March morning last year, the famously orange…

Will Palantir Crash?
Will Palantir Crash?

AI and data analytics software major Palantir (NASDAQ:PLTR) has been…

Is Target’s Dividend Worth Buying?
Is Target’s Dividend Worth Buying?

Retail giant Target (NYSE:TGT) has been through an extremely volatile…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 41x

Buy
59
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Sell
47
RGC alert for Jun 18

Regencell Bioscience Holdings [RGC] is up 30.47% over the past day.

Sell
20
ENPH alert for Jun 18

Enphase Energy [ENPH] is down 23.99% over the past day.

Sell
26
FSLR alert for Jun 18

First Solar [FSLR] is down 17.97% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock